Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen

Immunity

Volumn 15, Issue 4, 2001, Pages 579-589

  Sutkowski, Natalie ^a   Conrad, Bernard ^b   Thorley Lawson, David A ^a   Huber, Brigitte T ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; SUPERANTIGEN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENVELOPE GENE; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE; TRANSACTIVATION; VIRUS ACTIVATION; VIRUS INFECTION;

EID: 0034750690     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00210-2     Document Type: Article

References (50)

1. Interplays between mouse mammary tumor virus and the cellular and humoral immune response
2. Early events in Epstein-Barr virus infection of human B-lymphocytes
3. Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments
4. Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients
5. EBV persistence in memory B cells in vivo
6. Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans
7. Selective modulation of the major histocompatibility complex class II antigen presentation pathway following B cell receptor ligation and protein kinase C activation
8. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7
9. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens
10. Molecular characterization of Mls-1
11. The importance of exogenous antigen in priming the human CD8 (+) T cell response: Lessons from the EBV nuclear antigen EBNA1
12. Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine T cell hybridoma
13. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells
14. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo
15. Residues of the variable region of the T cell-receptor beta-chain that interact with S. aureus toxin superantigens
16. A method for production of antibodies to human T cell receptor beta-chain variable regions
17. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes
18. Bacterial superantigens reactivate antigen-specific CD8+ memory T cells
19. Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection
20. Alternative proteolytic processing of mouse mammary tumor virus superantigens
21. Enhanced HIV-1 replication in V beta 12 T cells due to human cytomegalovirus in monocytes: Evidence for a putative herpesvirus superantigen
22. A role for herpesvirus saimiri orf14 in transformation and persistent infection
23. Upstream elements of the MHC class II E beta gene active in B cells
24. Reactivity of mouse T cell hybridomas expressing human Vbeta gene segments with staphylococcal and streptococcal superantigens
25. Observations on memory B-cell development
26. Isolation and localization of an IDDMK1,2-22-related human endogenous retroviral gene, and identification of a CA repeat marker at its locus
27. Differential transcription from the long terminal repeats of integrated avian leukosis virus DNA
28. Association of Mouse Mammary Tumor Virus Superantigen with MHC class II during biosynthesis
29. Virus-encoded superantigens
30. Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-kappa B site
31. A simple method for displaying the hydropathic character of a protein
32. Germinal center development
33. Regulation of B-cell commitment to plasma cells or to memory B cells
34. The staphylococcal enterotoxins and their relatives
35. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
36. Proteolytic processing activates a viral superantigen
37. Transfer of a functional human immune system to mice with severe combined immunodeficiency
38. Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome
39. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line
40. Viral strategies of immune evasion
41. Interleukin-induced increase in Ia expression by normal mouse B cells
42. Interferon-α-induced endogenous superantigen: A model linking environment and autoimmunity
43. An Epstein-Barr virus-associated superantigen
44. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts
45. Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K
46. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: Role for a viral superantigen?
47. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation
48. Lymphoproliferative disease in human peripheral-blood-mononuclear-cell-injected scid mice. II. Role of host and donor factors in tumor generation
49. Herpesvirus saimiri open reading frame 14, a protein encoded by T lymphotropic herpesvirus, binds to MHC class II molecules and stimulates T cell proliferation
50. Antigen presentation in an HLA-DR-restricted fashion by B-cell chronic lymphocytic leukemia cells